The drug 5-aminosalicylic acid rescues alpha 1-proteinase inhibitor from the neutrophil oxidative inactivation. A possible contribution to its therapeutic action in ulcerative colitis.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 1521714)

Published in Digestion on January 01, 1992

Authors

L Ottonello1, P Dapino, G Pastorino, E Vitale, F Dallegri

Author Affiliations

1: Department of Internal Medicine, University of Genova Medical School, Italy.

Articles by these authors

Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature (1991) 4.77

Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet (1993) 2.29

Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. The International Marfan Syndrome Collaborative Study. N Engl J Med (1992) 1.95

Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: role of adenosine and proinflammatory cytokines. Rheumatology (Oxford) (2002) 1.82

Neutrophil dysfunction and increased susceptibility to infection. Eur J Clin Invest (1995) 1.45

Expressed cadherin pseudogenes are localized to the critical region of the spinal muscular atrophy gene. Proc Natl Acad Sci U S A (1995) 1.37

G to T transversion at position +5 of a splice donor site causes skipping of the preceding exon in the type III procollagen transcripts of a patient with Ehlers-Danlos syndrome type IV. J Biol Chem (1991) 1.27

Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes. J Immunol (1999) 1.26

Construction of a yeast artificial chromosome contig spanning the spinal muscular atrophy disease gene region. Proc Natl Acad Sci U S A (1993) 1.21

The anti-inflammatory drug nimesulide inhibits neutrophil adherence to and migration across monolayers of cytokine-activated endothelial cells. Respiration (1994) 1.15

Phase-II study of Navelbine in advanced breast cancer. Semin Oncol (1989) 1.09

The anti-inflammatory drug nimesulide rescues alpha-1-proteinase inhibitor from oxidative inactivation by phagocytosing neutrophils. Respiration (1992) 1.08

Antibody-dependent killing of tumor cells by polymorphonuclear leukocytes. Involvement of oxidative and nonoxidative mechanisms. J Natl Cancer Inst (1984) 1.07

Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells. J Natl Cancer Inst (2000) 1.07

Effect of anesthesia in a patient with pre-existing anisocoria. Eur Rev Med Pharmacol Sci (2011) 1.07

Right-sided bacterial endocarditis due to Flavobacterium odoratum in a patient on chronic hemodialysis. Am J Nephrol (1995) 1.03

Prostaglandin E2 inhibits apoptosis in human neutrophilic polymorphonuclear leukocytes: role of intracellular cyclic AMP levels. Exp Hematol (1998) 1.01

Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. J Clin Oncol (1988) 1.01

Mechanisms of tumour cell destruction by PMA-activated human neutrophils. Immunology (1983) 0.97

Inhibition of neutrophil cytolysin production by target cells. Blood (1986) 0.96

rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implications for B cell trafficking in secondary lymphoid tissues. J Immunol (1999) 0.95

Characterization of a type II collagen gene (COL2A1) mutation identified in cultured chondrocytes from human hypochondrogenesis. Proc Natl Acad Sci U S A (1992) 0.92

Antibody-dependent cellular cytotoxicity of leukaemic blast cells and neutrophils from patients with acute myelogenous leukaemia. Clin Exp Immunol (1982) 0.89

Tumor cell lysis by activated human neutrophils: analysis of neutrophil-delivered oxidative attack and role of leukocyte function-associated antigen 1. Inflammation (1991) 0.88

Nimesulide decreases superoxide production by inhibiting phosphodiesterase type IV. Eur J Pharmacol (1994) 0.88

Homogeneity of cystic fibrosis in Italy. Am J Hum Genet (1986) 0.87

Immune complex stimulation of neutrophil apoptosis: investigating the involvement of oxidative and nonoxidative pathways. Free Radic Biol Med (2001) 0.87

Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia. Atherosclerosis (1986) 0.86

Role of cytosolic calcium-dependent phospholipase A2 in Alzheimer's disease pathogenesis. Mol Neurobiol (2012) 0.85

Effects of ascorbic acid on neutrophil locomotion. Int Arch Allergy Appl Immunol (1980) 0.85

Down-regulation of K cell activity by neutrophils. Blood (1985) 0.84

Serum-associated inhibition of neutrophil Fc receptors in cancer patients. J Natl Cancer Inst (1981) 0.84

Ox erythrocyte cytotoxicity by phorbol myristate acetate-activated human neutrophils. Scand J Immunol (1983) 0.84

Evaluation of the effects induced by four opiate drugs, with different affinities to opioid receptor subtypes, on anterior pituitary LH, TSH, PRL and GH secretion and on cortisol secretion in normal men. Biomed Pharmacother (1986) 0.84

Evidence for a reversible functional state of neutrophil chemotactic deactivation. Int Arch Allergy Appl Immunol (1980) 0.84

Neutrophil-mediated cellular cytotoxicity triggered by immobilized aggregated IgG: an in vitro model of cell injury during immune complex diseases. J Clin Immunol (1984) 0.84

Repeating developmental expression of G-Hox 7, a novel homeobox-containing gene in the chicken. Dev Biol (1991) 0.84

Dexamethasone -induced apoptosis of human monocytes exposed to immune complexes. Intervention of CD95- and XIAP-dependent pathways. Int J Immunopathol Pharmacol (2005) 0.84

Induction of neutrophil respiratory burst by tumour necrosis factor-alpha; priming effect of solid-phase fibronectin and intervention of CD11b-CD18 integrins. Clin Exp Immunol (1993) 0.84

Erythrocyte lysis by PMA-triggered neutrophil polymorphonuclears: evidence for an hypochlorous acid-dependent process. Immunology (1985) 0.84

Linkage disequilibrium and haplotype analysis among Polish families with spinal muscular atrophy. Am J Hum Genet (1995) 0.84

Recombinant tumor necrosis factor enhances the locomotion of memory and naive B lymphocytes from human tonsils through the selective engagement of the type II receptor. Blood (1997) 0.83

Refinement of the spinal muscular atrophy locus by genetic and physical mapping. Am J Hum Genet (1995) 0.83

Neutrophil dysfunction and repeated infections: influence of levamisole and ascorbic acid. Br J Dermatol (1980) 0.83

Role of the oxidative metabolic burst in the antibody-dependent cellular cytotoxicity mediated by neutrophil polymorphonuclears. Exp Hematol (1982) 0.83

Cytoprotection against neutrophil-delivered oxidant attack by antibiotics. Biochem Pharmacol (1991) 0.83

Suggestive linkage of situs inversus and other left-right axis anomalies to chromosome 6p. J Med Genet (2001) 0.83

Stimulation of neutrophil chemotaxis, adhesiveness, phagocytosis, and hexose monophosphate shunt activity by N-(2-mercaptopropionyl)glycine. Res Exp Med (Berl) (1981) 0.82

In vitro effects of synthetic chemotactic peptides on neutrophil function. Int Arch Allergy Appl Immunol (1980) 0.82

Neutrophil functions in acne conglobata. Dermatologica (1979) 0.82

Inactivation of alpha-1-proteinase inhibitor by neutrophil metalloproteinases. Crucial role of the myeloperoxidase system and effects of the anti-inflammatory drug nimesulide. Respiration (1993) 0.82

Cyclic AMP-elevating agents down-regulate the oxidative burst induced by granulocyte-macrophage colony-stimulating factor (GM-CSF) in adherent neutrophils. Clin Exp Immunol (1995) 0.81

Enoxaparin in the prevention of deep venous thrombosis after major surgery: multicentric study. The Italian Study Group. Int Surg (1994) 0.81

Phase II study of tamoxifen and high-dose retinyl acetate in patients with advanced breast cancer. J Cancer Res Clin Oncol (1990) 0.81

Neutropenia and impaired neutrophil function in glycogenosis type Ib. J Inherit Metab Dis (1984) 0.81

Inhibitory effect of salmeterol on the respiratory burst of adherent human neutrophils. Clin Exp Immunol (1996) 0.81

Rio de La Plata study: a multicenter, cross-sectional study on cardiovascular risk factors and heart failure prevalence in peritoneal dialysis patients in Argentina and Uruguay. Kidney Int Suppl (2008) 0.80

Defective neutrophil chemotaxis corrected by levamisole in Crohn's disease. Acta Hepatogastroenterol (Stuttg) (1978) 0.80

Genomic cloning and characterization of the human thrombin receptor gene. Structural similarity to the proteinase activated receptor-2 gene. J Biol Chem (1996) 0.80

Sulphasalazine accelerates apoptosis in neutrophils exposed to immune complex: Role of caspase pathway. Clin Exp Pharmacol Physiol (2009) 0.80

Chemoattractant-induced release of elastase by lipopolysaccharide (LPS)-primed neutrophils; inhibitory effect of the anti-inflammatory drug nimesulide. Clin Exp Immunol (1997) 0.80

Reversal by cimetidine of histamine-induced inhibition of true chemotaxis in neutrophil polymorphonuclears. Res Exp Med (Berl) (1980) 0.80

Sulphonamides as anti-inflammatory agents: old drugs for new therapeutic strategies in neutrophilic inflammation? Clin Sci (Lond) (1995) 0.79

Clinical and genetic associations in Marfan syndrome and related disorders. Mt Sinai J Med (1992) 0.79

Erythrocyte lysis by monocytes: investigations on the mechanism and role of the target cell hydrogen peroxide catabolizing pathways. J Clin Lab Immunol (1987) 0.79

Triggering of respiratory burst by tumor necrosis factor in neutrophils adherent to fibronectin. Evidence for a crucial role of CD18 glycoproteins. Agents Actions (1994) 0.79

Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids. Metabolism (1990) 0.79

Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer. Cancer Treat Rep (1987) 0.79

Extracellular cytotoxicity by phagocytosing polymorphonuclear neutrophilic leukocytes: enhancement by a chemotactic stimulus. Exp Hematol (1985) 0.79

Monoclonal Lym-1 antibody-dependent cytolysis by neutrophils exposed to granulocyte-macrophage colony-stimulating factor: intervention of FcgammaRII (CD32), CD11b-CD18 integrins, and CD66b glycoproteins. Blood (1999) 0.78

Paclitaxel plus ifosfamide in advanced ovarian cancer: a multicenter phase II study. Oncology (1997) 0.78

Charged particle's flux measurement from PMMA irradiated by 80 MeV/u carbon ion beam. Phys Med Biol (2012) 0.78

Characterization of the human MSX-1 promoter and an enhancer responsible for retinoic acid induction. Cell Mol Biol Res (1994) 0.78

Activation of neutrophil respiratory burst by cytokines and chemoattractants. Regulatory role of extracellular matrix glycoproteins. Inflamm Res (1998) 0.78

A hospital based universal neonatal hearing screening programme using click-evoked otoacoustic emissions. Scand Audiol Suppl (2001) 0.78

Monoclonal Lym-1 antibody-dependent lysis of B-lymphoblastoid tumor targets by human complement and cytokinine-exposed mononuclear and neutrophilic polymorphonuclear leukocytes. Blood (1996) 0.78

Inhibition of the neutrophil oxidative response induced by the oral administration of nimesulide in normal volunteers. J Clin Lab Immunol (1992) 0.78

Lipids and other risk factors selected by discriminant analysis in symptomatic patients with supra-aortic and peripheral atherosclerosis. Circulation (1992) 0.78

Tumour necrosis factor alpha-induced oxidative burst in neutrophils adherent to fibronectin: effects of cyclic AMP-elevating agents. Br J Haematol (1995) 0.78